CNTX
CNTX
NASDAQ · Pharmaceuticals

Context Therapeutics Inc

$0.38
-0.01 (-1.67%)
As of Sep 23, 10:17 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +6,089.2% upside
Low Target $16.27
Average Target $23.68
High Target $31.54
Current Price $0.38
Current
$0.38
Target
$23.68
$16.27 $23.68 avg $31.54
Scenario Analysis
Bear Case
$16.27
4,152.5%
Low target
Base Case
$23.68
+6,089.2%
Avg target
Bull Case
$31.54
+8,143.6%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.62
-89.4% from high
52-Week Low
$0.34
+11.4% from low
Target vs 52W High
$23.68
+554.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +15.6%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +7.6%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +20.3%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +185.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -37.1%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +193.1%